Ribavirin for Lassa fever postexposure prophylaxis

doi:10.3201/eid1612.100994

. 2010 Dec;16(12):2009-11.

doi: 10.3201/eid1612.100994.

Ribavirin for Lassa fever postexposure prophylaxis

Christiane M Hadi, Augustine Goba, Sheik Humarr Khan, James Bangura, Mbalu Sankoh, Saffa Koroma, Baindu Juana, Alpha Bah, Mamadou Coulibaly, Daniel G Bausch

PMID: 21122249
PMCID: PMC3294560
DOI: 10.3201/eid1612.100994

Ribavirin for Lassa fever postexposure prophylaxis

Christiane M Hadi et al. Emerg Infect Dis. 2010 Dec.

. 2010 Dec;16(12):2009-11.

doi: 10.3201/eid1612.100994.

Authors

Christiane M Hadi, Augustine Goba, Sheik Humarr Khan, James Bangura, Mbalu Sankoh, Saffa Koroma, Baindu Juana, Alpha Bah, Mamadou Coulibaly, Daniel G Bausch

PMID: 21122249
PMCID: PMC3294560
DOI: 10.3201/eid1612.100994

No abstract available

PubMed Disclaimer

Figures

**Figure**
Adverse effects reported by 23 persons who took oral ribavirin prophylactically after potential exposure to Lassa virus, Sierra Leone, 2004.

See this image and copyright information in PMC

Cited by

Undiagnosed acute viral febrile illnesses, Sierra Leone.
Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN. Schoepp RJ, et al. Emerg Infect Dis. 2014 Jul;20(7):1176-82. doi: 10.3201/eid2007.131265. Emerg Infect Dis. 2014. PMID: 24959946 Free PMC article.
Lassa fever presenting as acute abdomen: a case series.
Dongo AE, Kesieme EB, Iyamu CE, Okokhere PO, Akhuemokhan OC, Akpede GO. Dongo AE, et al. Virol J. 2013 Apr 19;10:123. doi: 10.1186/1743-422X-10-123. Virol J. 2013. PMID: 23597024 Free PMC article.
A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
Cubitt B, Ortiz-Riano E, Cheng BY, Kim YJ, Yeh CD, Chen CZ, Southall NOE, Zheng W, Martinez-Sobrido L, de la Torre JC. Cubitt B, et al. Antiviral Res. 2020 Jan;173:104667. doi: 10.1016/j.antiviral.2019.104667. Epub 2019 Nov 28. Antiviral Res. 2020. PMID: 31786250 Free PMC article.
Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure.
Malhotra S, Yen JY, Honko AN, Garamszegi S, Caballero IS, Johnson JC, Mucker EM, Trefry JC, Hensley LE, Connor JH. Malhotra S, et al. PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2171. doi: 10.1371/journal.pntd.0002171. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23638192 Free PMC article.
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.
Caì Y, Iwasaki M, Beitzel BF, Yú S, Postnikova EN, Cubitt B, DeWald LE, Radoshitzky SR, Bollinger L, Jahrling PB, Palacios GF, de la Torre JC, Kuhn JH. Caì Y, et al. Viruses. 2018 Nov 20;10(11):655. doi: 10.3390/v10110655. Viruses. 2018. PMID: 30463334 Free PMC article.

See all "Cited by" articles

References

1. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20–6. 10.1056/NEJM198601023140104 - DOI - PubMed
1. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill. 2004;9:E11–2. - PubMed
1. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep. 1988;37(Suppl 3):1–16. - PubMed
1. Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990;323:1120–3. 10.1056/NEJM199010183231607 - DOI - PubMed
1. Johnson KM, Monath TP. Imported Lassa fever—reexamining the algorithms. N Engl J Med. 1990;323:1139–41. 10.1056/NEJM199010183231611 - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information

[1] McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20–6. 10.1056/NEJM198601023140104 - DOI - PubMed

[2] McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20–6. 10.1056/NEJM198601023140104 - DOI - PubMed

[3] Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill. 2004;9:E11–2. - PubMed

[4] Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill. 2004;9:E11–2. - PubMed

[5] Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep. 1988;37(Suppl 3):1–16. - PubMed

[6] Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep. 1988;37(Suppl 3):1–16. - PubMed

[7] Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990;323:1120–3. 10.1056/NEJM199010183231607 - DOI - PubMed

[8] Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990;323:1120–3. 10.1056/NEJM199010183231607 - DOI - PubMed

[9] Johnson KM, Monath TP. Imported Lassa fever—reexamining the algorithms. N Engl J Med. 1990;323:1139–41. 10.1056/NEJM199010183231611 - DOI - PubMed

[10] Johnson KM, Monath TP. Imported Lassa fever—reexamining the algorithms. N Engl J Med. 1990;323:1139–41. 10.1056/NEJM199010183231611 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ribavirin for Lassa fever postexposure prophylaxis

Ribavirin for Lassa fever postexposure prophylaxis

Authors

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical